While PPIs are generally considered safe for the general population, their use in cancer patients requires careful consideration. Potential risks include drug interactions with chemotherapeutic agents and the possibility of exacerbating certain side effects. Therefore, oncologists should evaluate the benefits and risks on a case-by-case basis.
